196 related articles for article (PubMed ID: 23181722)
21. Nuclear transcription factor CDX2 inhibits gastric cancer‑cell growth and reverses epithelial‑to‑mesenchymal transition in vitro and in vivo.
Zhang JF; Qu LS; Qian XF; Xia BL; Mao ZB; Chen WC
Mol Med Rep; 2015 Oct; 12(4):5231-8. PubMed ID: 26238762
[TBL] [Abstract][Full Text] [Related]
22. CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications.
Seno H; Oshima M; Taniguchi MA; Usami K; Ishikawa TO; Chiba T; Taketo MM
Int J Oncol; 2002 Oct; 21(4):769-74. PubMed ID: 12239615
[TBL] [Abstract][Full Text] [Related]
23. Prognostic influence of CDX2 expression in gastric carcinoma after surgery with a curative intent.
Estrada Muñoz L; García Gómez de Las Heras S; Díaz Del Arco C; Cerón Nieto MA; Chicharro Uriguen J; Fernández Aceñero MJ
Rev Esp Enferm Dig; 2019 Jul; 111(7):514-518. PubMed ID: 31140285
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
[TBL] [Abstract][Full Text] [Related]
25. Expression of CDX2 and villin in gastric cardiac intestinal metaplasia and the relation with gastric cardiac carcinogenesis.
Xiao ZY; Ru Y; Sun JT; Gao SG; Wang YF; Wang LD; Feng XS
Asian Pac J Cancer Prev; 2012; 13(1):247-50. PubMed ID: 22502678
[TBL] [Abstract][Full Text] [Related]
26. Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations.
Schildberg CW; Abba M; Merkel S; Agaimy A; Dimmler A; Schlabrakowski A; Croner R; Leupold JH; Hohenberger W; Allgayer H
Adv Med Sci; 2014 Mar; 59(1):142-6. PubMed ID: 24797991
[TBL] [Abstract][Full Text] [Related]
27. CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer.
Okayama H; Kumamoto K; Saitou K; Hayase S; Kofunato Y; Sato Y; Miyamoto K; Nakamura I; Ohki S; Sekikawa K; Takenoshita S
Oncol Rep; 2009 Oct; 22(4):745-55. PubMed ID: 19724852
[TBL] [Abstract][Full Text] [Related]
28. Genetic alterations of the Cdx2 gene in gastric cancer.
Song JH; Kim CJ; Cho YG; Chae JS; Cao Z; Nam SW; Lee JY; Park WS
APMIS; 2008 Jan; 116(1):74-80. PubMed ID: 18254783
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of caudal type homeobox transcription factor 2 inhibits the growth of the MGC-803 human gastric cancer cell line in vivo.
Wei W; Li L; Wang X; Yan L; Cao W; Zhan Z; Zhang X; Yu H; Xie Y; Xiao Q
Mol Med Rep; 2015 Jul; 12(1):905-12. PubMed ID: 25738600
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of Cdx2 inhibits progression of gastric cancer in vitro.
Xie Y; Li L; Wang X; Qin Y; Qian Q; Yuan X; Xiao Q
Int J Oncol; 2010 Feb; 36(2):509-16. PubMed ID: 20043087
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of CDX2 and Villin Expression in Advanced Stage Colorectal Carcinoma.
Altintas S; Bayrak M; Altintas Y
J Coll Physicians Surg Pak; 2019 Nov; 29(11):1057-1061. PubMed ID: 31659962
[TBL] [Abstract][Full Text] [Related]
32. CDX1/2 and KLF5 Expression and Epigenetic Modulation of Sonic Hedgehog Signaling in Gastric Adenocarcinoma.
Samadani AA; Nikbakhsh N; Taheri H; Shafaee S; Fattahi S; Pilehchian Langroudi M; Hajian K; Akhavan-Niaki H
Pathol Oncol Res; 2019 Jul; 25(3):1215-1222. PubMed ID: 30685841
[TBL] [Abstract][Full Text] [Related]
33. [Expressions of homeobox transcription factor-2 and E-cadherin in gastric carcinoma and their clinical significance].
Ge J; Chen ZH; Chen ZK; Yuan WJ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):279-1281. PubMed ID: 18250063
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
35. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
[TBL] [Abstract][Full Text] [Related]
36. The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer.
Hyun CL; Park SJ; Kim HS; Song HJ; Kim HU; Lee C; Lee DH; Maeng YH; Kim YS; Jang B
Anticancer Res; 2021 Jul; 41(7):3689-3698. PubMed ID: 34230168
[TBL] [Abstract][Full Text] [Related]
37. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
38. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions.
Kim HS; Lee JS; Freund JN; Min KW; Lee JS; Kim W; Juhng SW; Park CS
J Gastroenterol Hepatol; 2006 Feb; 21(2):438-42. PubMed ID: 16509871
[TBL] [Abstract][Full Text] [Related]
39. Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma.
Ide M; Kato T; Ogata K; Mochiki E; Kuwano H; Oyama T
Ann Surg Oncol; 2012 Oct; 19(11):3506-14. PubMed ID: 22695933
[TBL] [Abstract][Full Text] [Related]
40. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]